These are certainly not the ideal results that we were all hoping for, says Jason Kindrachuck, a virologist at the University of Manitoba in Winnipeg, Canada. Despite the hopes surrounding tecovirimat's use, the clinical trial's findings suggest that this antiviral does not provide the expected benefits in accelerating recovery from the monkeypox strain clade I. This highlights the ongoing challenges in effectively treating emerging infectious diseases, especially those that may evolve into more lethal forms.
The spread of clade I prompted the World Health Organization (WHO) to declare a public health emergency of international concern on 14 August, marking the highest alarm level for the organization. The Africa Centres for Disease Control and Prevention (Africa CDC) also declared its first-ever public health emergency over the outbreak, indicating the severity and urgency of the situation, especially given the concerning characteristics of this monkeypox strain.
Collection
[
|
...
]